Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug.
A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.
We cover the latest cancer research, including that funded by the charity. We also highlight other relevant material, debunk myths and media scares, and provide links to other helpful resources.
Text from Cancer Research UK Science blog by Cancer Research UK, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License.